| Literature DB >> 30384855 |
Maliwan Oofuvong1, Siriwimol Ratprasert2, Thavat Chanchayanon2.
Abstract
BACKGROUND: We aimed to construct a prediction tool for postoperative oxygen therapy and determine predictors of duration of use among children undergoing non-cardiac surgery.Entities:
Keywords: Duration of use; Pediatric anesthesia; Postoperative oxygen therapy; Predictors
Mesh:
Year: 2018 PMID: 30384855 PMCID: PMC6214164 DOI: 10.1186/s12871-018-0595-4
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Demographic data among children who received postoperative oxygen therapy compared with those who did not
| Factor | No oxygen therapy | Oxygen therapy | |
|---|---|---|---|
| Age (years) | 0.99 | ||
| <1 | 216 (18.8) | 54 (18.8) | |
| 1–6 | 552 (47.9) | 138 (47.9) | |
| >6 | 384 (33.3) | 96 (33.3) | |
| Male | 684 (59.4) | 182 (63.2) | 0.26 |
| Weight, median (IQR) (kg) | 16.0 (9.8-25.0) | 14.3 (8.4-33.4) | 0.41 |
| Height, median (IQR) (cm) | 104.0 (80-128.0) | 98.5 (75.0-130.0) | 0.19 |
| Body mass index (kg/m2) | <0.001* | ||
| 5–14.9 | 479 (41.6) | 130 (45.1) | |
| 15–24.9 | 629 (54.6) | 128 (44.4) | |
| 25-60 | 44 (3.8) | 30 (10.4) | |
| URI (Y/N) | 72 (6.2)/1080 (93.8) | 23 (8)/265 (92.0) | 0.35 |
| Pulmonary disease (Y/N) | 8 (0.7)/1144 (99.3) | 16 (5.6)/272 (94.4) | <0.001* |
| Hyper-reactive airway (Y/N) | 65 (5.6)/1087 (94.4) | 24 (8.3)/264 (91.7) | 0.12 |
| Anemia (Y/N) | 526 (45.7)/626 (54.3) | 127 (44.1)/161 (55.9) | 0.68 |
| Snoring (Y/N) | 14 (1.2)/1138 (98.8) | 4 (1.4)/284 (98.6) | 0.95 |
| Non-cyanotic heart (Y/N) | 41 (3.6)/1111 (96.4) | 30 (10.4)/258 (89.6) | <0.001* |
| Probable difficult airway (Y/N) | 12 (1.0)/1140 (99.0) | 21 (7.3)/267 (92.7) | <0.001* |
| Risk of aspiration (Y/N) | 24 (2.1)/1128 (97.9) | 11 (3.8)/277 (96.2) | 0.13 |
| Delayed development (Y/N) | 34 (3.0)/1118 (97.0) | 22 (7.6)/266 (92.4) | <0.001* |
Data are presented as frequency (percentage) unless otherwise stated
*<0.05 by chi-squared test
IQR inter-quartile range, URI Upper respiratory tract infection
Anesthesia- and surgical-related risk among children who received postoperative oxygen therapy compared with those who did not
| Factor | No oxygen therapy | Oxygen therapy | |
|---|---|---|---|
| ASA physical status | <0.001* | ||
| 1 | 242 (21.0) | 21 (7.3) | |
| 2 | 742 (64.4) | 136 (47.2) | |
| 3 | 168 (14.6) | 131 (45.5) | |
| Type of case | <0.001* | ||
| Elective | 984 (85.4) | 212 (73.6) | |
| Emergency | 168 (14.6) | 76 (26.4) | |
| Site/ type of procedure | <0.001* | ||
| Eye | 226 (19.6) | 11 (3.8) | |
| Urologic | 212 (18.4) | 33 (11.5) | |
| Airway | 187 (16.2) | 66 (22.9) | |
| Ear-nose-face | 93 (8.1) | 19 (6.6) | |
| Thoracic | 2 (0.2) | 23 (8.0) | |
| Intra-abdomen | 84 (7.3) | 49 (17.0) | |
| Orthopedic | 238 (20.7) | 50 (17.4) | |
| Intra-cranial | 14 (1.2) | 9 (3.1) | |
| Gastrointestinal scope | 53 (4.6) | 13 (4.5) | |
| Cardiac catheterization | 43 (3.7) | 15 (5.2) | |
| Choice of anesthesia | 0.04* | ||
| GA only | 948 (82.3) | 252 (87.5) | |
| GA with epidural/caudal | 151 (13.1) | 31 (10.8) | |
| GA with peripheral nerve block | 53 (4.6) | 5 (1.7) | |
| Airway device | <0.001* | ||
| Facemask/laryngeal mask airway | 411 (35.7) | 31 (10.8) | |
| Spontaneous breathing with non-rebreathing mask | 28 (2.4) | 4 (1.4) | |
| Endotracheal tube intubation | 713 (61.9) | 253 (87.8) | |
| Neuromuscular blocking agent | <0.001* | ||
| Succinylcholine | 84 (7.3) | 45 (15.6) | |
| Aminosteroid derivatives | 39 (3.4) | 29 (10.1) | |
| Benzylisoquinolines | 456 (39.6) | 141 (49.0) | |
| None | 573 (49.7) | 73 (25.3) | |
| Inhalation agent | 0.99 | ||
| Sevoflurane | 945 (82.0) | 236 (81.9) | |
| Desflurane | 24 (2.1) | 6 (2.1) | |
| None | 183 (15.9) | 46 (16.0) | |
| Narcotic | 0.006* | ||
| Fentanyl | 841 (73.0) | 204 (70.8) | |
| Morphine | 100 (8.7) | 42 (14.6) | |
| None | 211 (18.3) | 42 (14.6) | |
| Anesthetic time (hour) | <0.001* | ||
| <1 | 281 (24.4) | 27 (9.4) | |
| 1–<3 | 737 (64.0) | 201 (69.8) | |
| ≥3 | 134 (11.6) | 60 (20.8) | |
| PRAE | <0.001* | ||
| None | 1,130 (98.1) | 129 (44.8) | |
| Upper airway obstruction | 0 (0) | 9 (3.1) | |
| Laryngospasm | 9 (0.8) | 3 (1.0) | |
| Desaturation | 7 (0.6) | 126 (43.8) | |
| Bronchospasm/wheezing | 6 (0.5) | 21 (7.3) |
Data are presented as frequency (percentage) unless otherwise stated
*<0.05 by chi-squared test
ASA American Society of Anesthesiologists, GA General anesthesia, PRAE Perioperative respiratory adverse events
Fig. 1Flow diagram of the study. GA General anesthesia, ASA American Society of Anesthesiologists
Multivariate hurdle model of factors predicting postoperative oxygen therapy use and risk scores in children undergoing non-cardiac surgery
| Factor | Coefficient | Adjusted OR (95% CI) | Risk score | |
|---|---|---|---|---|
| Body mass index (Ref: 15-24.9) | ||||
| 5–14.9 | 0.51 | 1.66 (1.07, 2.58) | 0.024 | 1 |
| 25-60 | 1.04 | 2.82 (1.30, 6.11) | 0.009 | 2 |
| Hyper-reactive airway (Ref: No) | ||||
| Yes | 0.92 | 2.50 (1.12, 5.59) | 0.025 | 2 |
| Probable difficult airway (Ref: No) | ||||
| Yes | 1.61 | 4.99 (1.74, 14.32) | 0.003 | 3 |
| ASA physical status (Ref: 1) | ||||
| 2 | 0.31 | 1.36 (0.73, 2.53) | 0.327 | 0 |
| 3 | 1.55 | 4.73 (2.43, 9.18) | <0.001 | 3 |
| Site/ type of procedure (Ref: Eye) | ||||
| Urologic | 1.46 | 4.32 (1.39, 13.41) | 0.01 | 3 |
| Airway | 2.04 | 7.72 (2.62, 22.70) | 0.0002 | 4 |
| Ear-nose-face | 0.82 | 2.27 (0.60, 8.52) | 0.22 | 0 |
| Thoracic | 5.63 | 277.9 (44.56, 1733) | <0.0001 | 11 |
| Intra-abdomen | 1.96 | 7.12 (2.30, 22.04) | 0.0007 | 4 |
| Orthopedic | 1.95 | 7.00 (2.30, 21.33) | 0.0006 | 4 |
| Intra-cranial | 2.01 | 7.45 (1.62, 34.20) | 0.01 | 4 |
| Gastrointestinal scope | 1.23 | 3.42 (0.88, 13.37) | 0.07 | 0 |
| Cardiac catheterization | 1.98 | 7.28 (2.04, 25.96) | 0.002 | 4 |
| Airway device (Ref: Facemask/LMA) | ||||
| Spontaneous breathing with non- rebreathing mask | 1.38 | 3.98 (0.64, 24.88) | 0.14 | 0 |
| Endotracheal tube intubation | 1.89 | 6.64 (2.54, 17.32) | 0.0001 | 4 |
| Neuromuscular blocking agent (Ref: None) | ||||
| Succinylcholine | 0.67 | 1.95 (0.92, 4.13) | 0.080 | 0 |
| Aminosteroid derivatives | 1.06 | 2.89 (1.18, 7.05) | 0.02 | 2 |
| Benzylisoquinolines | 0.07 | 1.07 (0.58, 1.96) | 0.83 | 0 |
| Anesthetic time (hours) (Ref: <1) | ||||
| 1–2.9 | 1.09 | 2.99 (1.38, 6.44) | 0.005 | 2 |
| ≥3 | 1.57 | 4.79 (1.99, 11.6) | 0.0005 | 3 |
| PRAE (Ref: None) | ||||
| UAO and laryngospasm | 4.12 | 61.5 (14.4, 262) | <0.0001 | 8 |
| Desaturation | 6.18 | 481.2 (177.9, 1302) | <0.0001 | 12 |
| Bronchospasm/wheezing | 4.53 | 92.4 (29.7, 288) | <0.0001 | 9 |
Ref Reference group; OR Odds ratio, CI Confidence interval, ASA American Society of Anesthesiologists, LMA Laryngeal mask airway, UAO Upper airway obstruction, PRAE Perioperative respiratory adverse events
Fig. 2Receiver operating characteristic curve of the risk score predicting postoperative oxygen therapy
Multivariate hurdle model of factors predicting duration of postoperative oxygen therapy use in children undergoing non-cardiac surgery
| Factor | Adjusted count ratio | |
|---|---|---|
| Probable difficult airway | 2.19 (1.39, 3.48) | 0.0008 |
| History of delayed development | 2.31 (1.49, 3.57) | 0.0002 |
| ASA physical status (Ref: 1) | 0.03a | |
| 2 | 0.75 (0.43, 1.32) | |
| 3 | 1.07 (0.61, 1.88) | |
| Site/type of procedure (Ref: Eye) | <0.0001 | |
| Urologic | 1.98 (0.99, 3.96) | |
| Airway | 3.01 (1.55, 5.83) | |
| Ear-nose-face | 2.27 (1.06, 4.82) | |
| Thoracic | 4.86 (2.34, 10.1) | |
| Intra-abdomen | 4.15 (2.13, 8.11) | |
| Orthopedic | 2.14 (1.08, 4.25) | |
| Intra-cranial | 1.26 (0.52, 3.02) | |
| Gastrointestinal scope | 2.73 (1.23, 6.04) | |
| Cardiac catheterization | 1.18 (0.53, 2.60) | |
| Narcotic used (Ref: None) | 0.049b | |
| Morphine | 0.69 (0.40, 1.20) | |
| Fentanyl | 1.10 (0.72, 1.68) |
Ref Reference group, ASA American Society of Anesthesiologists
aThe contrast of ASA physical status 3 vs ASA physical status 2 gave a significant count ratio of 1.42 and 95% CI of 1.10 and 1.84.
bThe contrast of morphine vs fentanyl gave a significant count ratio of 0.63 and 95% CI of 0.44 and 0.90.